Faith E. Davies, MD

Professor in the Department of Medicine, and director of the Clinical Myeloma Program at NYU Langone Health’s Perlmutter Cancer Center

Articles by Faith E. Davies, MD

Next Steps for Car T-Cell Therapy in Multiple Myeloma: Faith E. Davies, MD

ByFaith E. Davies, MD

July 6th 2021

The director of the Clinical Myeloma Program at NYU Langone Health’s Perlmutter Cancer Center discusses the next steps for CAR T-cell therapy in the treatment of patients with relapsed/refractory multiple myeloma.

Faith E. Davies, MD

Articles by Faith E. Davies, MD

Next Steps for Car T-Cell Therapy in Multiple Myeloma: Faith E. Davies, MD

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial